Download presentation
Presentation is loading. Please wait.
Published byこうじ そめや Modified over 5 years ago
1
Management and Outcomes of Heterotaxy Syndrome Associated With Pulmonary Atresia or Pulmonary Stenosis Vinod A. Sebastian, MD, Javier Brenes, MD, Raghav Murthy, MD, Surendranath Veeram Reddy, MD, V. Vivian Dimas, MD, Alan Nugent, MBBS, Thomas Zellers, MD, Rong Huang, MS, Kristine J. Guleserian, MD, Joseph M. Forbess, MD The Annals of Thoracic Surgery Volume 98, Issue 1, Pages (July 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Algorithm for management of heterotaxy with pulmonary atresia/pulmonary stenosis. (TAPVR = total anomalous pulmonary venous return.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Clinical management of heterotaxy with pulmonary atresia/pulmonary stenosis. (TAPVR = total anomalous pulmonary venous return.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
4
Fig 3 Kaplan-Meier survival curve (blue line) is shown with the 95% confidence limits (range bars), with circles indicating censored patients. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
5
Fig 4 Survival comparison is shown between heterotaxy patients with pulmonary atresia/pulmonary stenosis with total anomalous pulmonary venous return (TAPVR; dashed red line; red circles indicating censored patients) and those without TAPVR (solid blue line, blue circles indicating censored patients). Log-rank test showed significantly worsened survival in the TAPVR group (p = 0.038). The range bars show the 95% confidence limits. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
6
Fig 5 Survival comparison is shown between heterotaxy patients with pulmonary atresia (PA)/pulmonary stenosis (PS) with total anomalous pulmonary venous return (TAPVR) who underwent operations at less than 30 days of age (solid red line; red circles indicating censored patients) vs the remaining patients in the cohort (dashed blue line, blue circles indicating censored patients). The log-rank test showed significant difference in survival between the two groups (p = 0.001). The range bars show the 95% confidence limits. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
7
Fig 6 Drawing shows a patient with a left aortic arch and bilaterally discontinuous pulmonary arteries (PAs). (Ao = aorta; RA = right atrium; RPA = right pulmonary artery; RV = right ventricle; SVC = superior vena cava.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
8
Fig 7 Surgical reconstruction is shown in a patient with left aortic arch and bilaterally discontinuous pulmonary arteries. After ductal resection, the right subclavian artery and left carotid artery are used to reconstruct right and left pulmonary artery respectively. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
9
Fig 8 Drawing shows patient with right aortic arch and bilaterally discontinuous pulmonary arteries. (LPA = left pulmonary artery; RPA = right pulmonary artery.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
10
Fig 9 Surgical reconstruction is shown in a patient with a right aortic arch and bilaterally discontinuous pulmonary arteries. After ductal resection, the right carotid artery and left subclavian artery are used to reconstruct right and left pulmonary artery respectively. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.